IQI
PRAX icon

Integrated Quantitative Investments’s Praxis Precision Medicines PRAX Stock Holding History

Integrated Quantitative Investments’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
3,173
+1,920
+153% +$608K 0.17% 216
2026
Q1 		$404K Buy
+1,253
New +$388K 0.07% 285

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Integrated Quantitative Investments's PRAX Position: Q2 2026 in Review

Integrated Quantitative Investments increased its Praxis Precision Medicines (PRAX) stake by 153% in Q2 2026, buying an estimated $608K and bringing the position to 3,173 shares worth $1.06M. The position accounts for 0.17% of the portfolio, ranked #216.

Integrated Quantitative Investments first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Integrated Quantitative Investments held 3,173 shares of Praxis Precision Medicines worth $1.06M as of Q2 2026.
  • Integrated Quantitative Investments bought 1,920 Praxis Precision Medicines shares in Q2 2026, an estimated $608K.
  • Praxis Precision Medicines made up 0.17% of Integrated Quantitative Investments's portfolio in Q2 2026, its #216 holding.
  • Integrated Quantitative Investments first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.